• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

Brief cognitive screening tool in development

October 5, 2013  

HSCT in aggressive MS: Canadian MS/BMT Study Group results

October 5, 2013  

Lateral switch vs. escalation: 2 reports

October 5, 2013  

Identifying SPMS in practice

October 4, 2013  

MS therapies: analyses and re-analyses of phase III studies

October 4, 2013  

Dietary sodium linked to increased disease activity in MS

October 4, 2013  

MRI measures provide reliable indication of treatment response

October 3, 2013  

Better prognosis for OCB-negative patients

October 3, 2013  

Vitamin D a useful add-on treatment in MS

October 3, 2013  

Optimizing treatment of RRMS: Canadian recommendations

September 4, 2013  
Previous
33
34
35
36
37
Next

Browse by Topic

  • MS (444)
  • CLINICAL CASES (22)
  • EAN 2026 (2)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Ofatumumab 2026 – update on real-world effectiveness posted on September 22, 2026
  • CLINICAL CASES IN NEUROLOGY – A YOUNG WOMAN WITH MILD EARLY MS posted on September 17, 2026
  • Highlights of EAN 2026 – Part 2 posted on July 9, 2026
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions